Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive, HER2-negative breast cancer: final overall survival analysis of the phase III TROPION-Breast01 study
Year: 2025
Type: article
Language: en
Topic: HER2/EGFR in Cancer Research
Authors and affiliations:
raw_author_name: B. Pistilli
raw_affiliation_strings: Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France
raw_author_name: K. Jhaveri
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA
raw_author_name: S.-A. Im
raw_affiliation_strings: Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea
raw_author_name: S. Pernas
raw_affiliation_strings: Institut Català d'Oncologia, IDIBELL, L'Hospitalet, Barcelona, Spain
raw_author_name: M. De Laurentiis
raw_affiliation_strings: Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Naples, Italy
raw_author_name: S. Wang
raw_affiliation_strings: Cancer Center of Sun Yat-sen University, Guangzhou, China
raw_author_name: N. Martínez Jañez
raw_affiliation_strings: Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
raw_author_name: G. Borges
raw_affiliation_strings: Catarina Pesquisa Clínica, Itajaí, Brazil
raw_author_name: D.W. Cescon
raw_affiliation_strings: Princess Margaret Cancer Centre/UHN, Toronto, Canada
raw_author_name: M. Hattori
raw_affiliation_strings: Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan; Aichi Breast Clinic Hirabari, Nagoya, Japan
raw_author_name: Y.-S. Lu
raw_affiliation_strings: National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
raw_author_name: E. Hamilton
raw_affiliation_strings: Sarah Cannon Research Institute, Nashville, USA
raw_author_name: J. Tsurutani
raw_affiliation_strings: Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan
raw_author_name: K. Kalinsky
raw_affiliation_strings: Winship Cancer Institute at Emory University, Atlanta, USA
raw_author_name: P.E. Rubini Liedke
raw_affiliation_strings: Hospital das Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil; UPCO-Pesquisa Clinica em Oncologia, Porto Alegre, Brazil; Oncoclinicas Porto Alegre, Porto Alegre, Brazil
raw_author_name: D. Carroll
raw_affiliation_strings: Translational Medicine, Late-Stage Development, Oncology Research & Development, AstraZeneca, Cambridge, UK
raw_author_name: S. Khan
raw_affiliation_strings: Clinical Development, Late-Stage Development, Oncology Research and Development, AstraZeneca, Gaithersburg, USA
raw_author_name: H.S. Rugo
raw_affiliation_strings: University of California San Francisco Comprehensive Cancer Center, San Francisco, USA
raw_author_name: B. Xu
raw_affiliation_strings: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
raw_author_name: A. Bardia
raw_affiliation_strings: Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, USA; Massachusetts General Hospital Cancer Center, Boston, USA. Electronic address: ABardia@mednet.ucla.edu